Ignite Creation Date:
2024-05-06 @ 3:10 PM
Last Modification Date:
2024-10-26 @ 1:44 PM
Study NCT ID:
NCT04541017
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2020-09-05
Brief Title:
Testing the Addition of an Anti-cancer Drug Hu5F9-G4 Magrolimab to the Usual Chemotherapy Treatment Mogamulizumab in T-Cell a Type of Immune Cell Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-05
First Submit QC Date:
September 5 2020
Study First Post Date:
2020-09-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-02
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL